Optimization of recombinant antibody production based on the vector design and the level of metabolites for generation of Ig- producing stable cell lines

Abstract Background The biopharmaceutical industry is significantly growing worldwide, and the Chinese hamster ovary (CHO) cells are used as a main expression host for the production of recombinant monoclonal antibodies. Various metabolic engineering approaches have been investigated to generate cel...

Full description

Bibliographic Details
Main Authors: V. A. Toporova, V. V. Argentova, T. K. Aliev, A. A. Panina, D. A. Dolgikh, M. P. Kirpichnikov
Format: Article
Language:English
Published: SpringerOpen 2023-02-01
Series:Journal of Genetic Engineering and Biotechnology
Subjects:
Online Access:https://doi.org/10.1186/s43141-023-00474-0
_version_ 1797863871098126336
author V. A. Toporova
V. V. Argentova
T. K. Aliev
A. A. Panina
D. A. Dolgikh
M. P. Kirpichnikov
author_facet V. A. Toporova
V. V. Argentova
T. K. Aliev
A. A. Panina
D. A. Dolgikh
M. P. Kirpichnikov
author_sort V. A. Toporova
collection DOAJ
description Abstract Background The biopharmaceutical industry is significantly growing worldwide, and the Chinese hamster ovary (CHO) cells are used as a main expression host for the production of recombinant monoclonal antibodies. Various metabolic engineering approaches have been investigated to generate cell lines with improved metabolic characteristics for increasing longevity and mAb production. A novel cell culture method based on the 2-stage selection makes it possible to develop a stable cell line with high-quality mAb production. Results We have constructed several design options of mammalian expression vectors for the high production of recombinant human IgG antibodies. Versions for bipromoter and bicistronic expression plasmids different in promoter orientation and cistron arrangements were generated. The aim of the work presented here was to assess a high-throughput mAb production system that integrates the advantages of high-efficiency cloning and stable cell clones to stage strategy selection reducing the time and effort required to express therapeutic monoclonal mAbs. Development of a stable cell line using bicistronic construct with EMCV IRES-long link gave an advantage in high mAb expression and long-term stability. Two-stage selection strategies allowed the elimination of low-producer clones by using metabolic level intensity to estimate the IgG production in the early steps of selection. The practical application of the new method allows to reduce time and costs during stable cell line development.
first_indexed 2024-04-09T22:42:35Z
format Article
id doaj.art-5e688550cea44f9d97a87acd76137fe4
institution Directory Open Access Journal
issn 2090-5920
language English
last_indexed 2024-04-09T22:42:35Z
publishDate 2023-02-01
publisher SpringerOpen
record_format Article
series Journal of Genetic Engineering and Biotechnology
spelling doaj.art-5e688550cea44f9d97a87acd76137fe42023-03-22T12:02:31ZengSpringerOpenJournal of Genetic Engineering and Biotechnology2090-59202023-02-0121111010.1186/s43141-023-00474-0Optimization of recombinant antibody production based on the vector design and the level of metabolites for generation of Ig- producing stable cell linesV. A. Toporova0V. V. Argentova1T. K. Aliev2A. A. Panina3D. A. Dolgikh4M. P. Kirpichnikov5Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya ul. 16/10, GSP-7Department of Bioengineering, Biology Faculty, Lomonosov Moscow State UniversityDepartment of Chemical Enzymology, School of Chemistry, Lomonosov Moscow State UniversityShemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya ul. 16/10, GSP-7Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya ul. 16/10, GSP-7Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya ul. 16/10, GSP-7Abstract Background The biopharmaceutical industry is significantly growing worldwide, and the Chinese hamster ovary (CHO) cells are used as a main expression host for the production of recombinant monoclonal antibodies. Various metabolic engineering approaches have been investigated to generate cell lines with improved metabolic characteristics for increasing longevity and mAb production. A novel cell culture method based on the 2-stage selection makes it possible to develop a stable cell line with high-quality mAb production. Results We have constructed several design options of mammalian expression vectors for the high production of recombinant human IgG antibodies. Versions for bipromoter and bicistronic expression plasmids different in promoter orientation and cistron arrangements were generated. The aim of the work presented here was to assess a high-throughput mAb production system that integrates the advantages of high-efficiency cloning and stable cell clones to stage strategy selection reducing the time and effort required to express therapeutic monoclonal mAbs. Development of a stable cell line using bicistronic construct with EMCV IRES-long link gave an advantage in high mAb expression and long-term stability. Two-stage selection strategies allowed the elimination of low-producer clones by using metabolic level intensity to estimate the IgG production in the early steps of selection. The practical application of the new method allows to reduce time and costs during stable cell line development.https://doi.org/10.1186/s43141-023-00474-0Bipromoter/bicistronic plasmidExpression vectorLevel metabolitesmAbs productionStable cell lines
spellingShingle V. A. Toporova
V. V. Argentova
T. K. Aliev
A. A. Panina
D. A. Dolgikh
M. P. Kirpichnikov
Optimization of recombinant antibody production based on the vector design and the level of metabolites for generation of Ig- producing stable cell lines
Journal of Genetic Engineering and Biotechnology
Bipromoter/bicistronic plasmid
Expression vector
Level metabolites
mAbs production
Stable cell lines
title Optimization of recombinant antibody production based on the vector design and the level of metabolites for generation of Ig- producing stable cell lines
title_full Optimization of recombinant antibody production based on the vector design and the level of metabolites for generation of Ig- producing stable cell lines
title_fullStr Optimization of recombinant antibody production based on the vector design and the level of metabolites for generation of Ig- producing stable cell lines
title_full_unstemmed Optimization of recombinant antibody production based on the vector design and the level of metabolites for generation of Ig- producing stable cell lines
title_short Optimization of recombinant antibody production based on the vector design and the level of metabolites for generation of Ig- producing stable cell lines
title_sort optimization of recombinant antibody production based on the vector design and the level of metabolites for generation of ig producing stable cell lines
topic Bipromoter/bicistronic plasmid
Expression vector
Level metabolites
mAbs production
Stable cell lines
url https://doi.org/10.1186/s43141-023-00474-0
work_keys_str_mv AT vatoporova optimizationofrecombinantantibodyproductionbasedonthevectordesignandthelevelofmetabolitesforgenerationofigproducingstablecelllines
AT vvargentova optimizationofrecombinantantibodyproductionbasedonthevectordesignandthelevelofmetabolitesforgenerationofigproducingstablecelllines
AT tkaliev optimizationofrecombinantantibodyproductionbasedonthevectordesignandthelevelofmetabolitesforgenerationofigproducingstablecelllines
AT aapanina optimizationofrecombinantantibodyproductionbasedonthevectordesignandthelevelofmetabolitesforgenerationofigproducingstablecelllines
AT dadolgikh optimizationofrecombinantantibodyproductionbasedonthevectordesignandthelevelofmetabolitesforgenerationofigproducingstablecelllines
AT mpkirpichnikov optimizationofrecombinantantibodyproductionbasedonthevectordesignandthelevelofmetabolitesforgenerationofigproducingstablecelllines